April 23, 2021

Does Taking an Angiotensin Inhibitor Increase the Risk for COVID-19? – A Systematic Review and Meta-Analysis

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

Keywords (Tags): risk factor

• A systematic review and meta-analysis found no association between angiotensin inhibitor (ACE) use and COVID-19 severity or mortality. The authors suggest that these data may indicate that the presence of hypertension, rather than the use of ACEs, is a greater risk factor for severe COVID-19 outcomes. The authors conclude that there is no evidence to support discontinuation of ACE drugs to prevent COVID-19-associated morbidity.

Ma et al. (Apr 2021). Does Taking an Angiotensin Inhibitor Increase the Risk for COVID-19? – A Systematic Review and Meta-Analysis. Aging. https://doi.org/10.18632/aging.202902